|
2024
|
Invention
|
Methods and compositions for treatment of geographic atrophy. The invention provides methods, com... |
|
|
Invention
|
Methods and compositions for preventing the progression of diabetic retinopathy and related condi... |
|
2023
|
Invention
|
Salts and esters of apx3330 and therapeutic uses thereof. This invention relates to Compound 1 (A... |
|
2022
|
Invention
|
Highly pure phentolamine mesylate and methods for making same. This invention provides methods fo... |
|
|
Invention
|
Methods and compositions for treatment of diabetic retinopathy and related conditions. The invent... |
|
|
Invention
|
Methods and compositions for treating mydriasis, glaucoma, and other ocular conditions. The inven... |
|
2019
|
Invention
|
Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders. The ... |
|
|
Invention
|
Methods and compositions for treatment of glaucoma and related conditions. Methods, compositions ... |
|
2018
|
Invention
|
Quinoxalinyl-piperazinamide methods of use. The disclosed subject matter provides methods using a... |
|
2017
|
Invention
|
Fluorocyclopentenylcytosine methods of use. The disclosed subject matter provides methods using a... |
|
|
Invention
|
Nanoparticulate compositions and formulations of piperazine compounds. The present invention rela... |
|
2016
|
Invention
|
Process for the preparation of 4-amino 1-((1s,4r,5s)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclo... |
|
2015
|
Invention
|
Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl)methanone compounds. Tetrahydroisoquinolin-2-yl-(quin... |
|
|
Invention
|
Process or the preparation of 4-amino 1-((1s,4r,5s)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclop... |
|
2014
|
Invention
|
Process for the preparation of 4-amino-1-((1s,4r,5s)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclo... |
|
2012
|
Invention
|
1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives for tr... |
|
2011
|
Invention
|
5, 6, or 7-substituted -3-(hetero) arylisoquinolinamine derivatives and therapeutic use thereof. ... |
|
2010
|
Invention
|
Polymeric systems for the delivery of anticancer drugs. The present invention relates to composit... |
|
2008
|
Invention
|
Quinazoline derivatives and therapeutic use thereof. Quinazoline derivatives represented by the g... |
|
2007
|
Invention
|
5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives and therapeutic use thereof. Th... |
|
2005
|
Invention
|
1-[6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives. The pr... |
|
|
Invention
|
Nucleoside derivatives and therapeutic use thereof. The present invention relates to nucleoside d... |
|
2004
|
Invention
|
Ophthalmic formulations including selective alpha 1 antagonists. Ophthalmic formulations are prov... |
|
|
Invention
|
Night vision composition. A method for optimizing pupil size in individuals suffering from excess... |
|
|
Invention
|
Antisense oligonucleotides that inhibit expression of hif-1. New antisense oligonucleotide compou... |
|
2003
|
Invention
|
Use of antisense oligonucleotides to inhibit the expression of human akt-1. New antisense oligonu... |
|
2002
|
Invention
|
Ophthalmic formulation which modulates dilation. An ophthalmic formulation is disclosed which red... |
|
2000
|
Invention
|
Method for optimizing pupil size using alpha antagonist. A method for optimizing pupil size in in... |
